-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PhsVR1v2mS4Gly5BHdnhDrb2MsX6IQ7s0t29WEF68sYV5BdbngJU5syxZCx8hm+C D0ONDkMsF0g7Ngk5vKAhPg== 0000895345-08-000636.txt : 20081210 0000895345-08-000636.hdr.sgml : 20081210 20081210165539 ACCESSION NUMBER: 0000895345-08-000636 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20081210 DATE AS OF CHANGE: 20081210 GROUP MEMBERS: CARLO BELLINI GROUP MEMBERS: DR. FRANCESCO BELLINI GROUP MEMBERS: FMRC FAMILY TRUST GROUP MEMBERS: JOHN W. CHURCHILL GROUP MEMBERS: P. P. LUXCO HOLDINGS II S.A.R.L. GROUP MEMBERS: PICCHIO PHARMA INC. GROUP MEMBERS: ROBERTO BELLINI GROUP MEMBERS: VERNON H. STRANG GROUP MEMBERS: VICTORIA SQUARE VENTURES INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BELLUS Health Inc. CENTRAL INDEX KEY: 0001259942 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79463 FILM NUMBER: 081241543 BUSINESS ADDRESS: STREET 1: 275 ARMAND-FRAPPIER BLVD. CITY: LAVAL STATE: A8 ZIP: H7V 4A7 BUSINESS PHONE: 450-680-4500 MAIL ADDRESS: STREET 1: 275 ARMAND-FRAPPIER BLVD. CITY: LAVAL STATE: A8 ZIP: H7V 4A7 FORMER COMPANY: FORMER CONFORMED NAME: NEUROCHEM INC DATE OF NAME CHANGE: 20030814 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Power Technology Investment CORP CENTRAL INDEX KEY: 0001289188 IRS NUMBER: 980361869 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 751 VICTORIA SQUARE CITY: MONTREAL STATE: A8 ZIP: H2Y 2J3 BUSINESS PHONE: (514) 286-7453 MAIL ADDRESS: STREET 1: 751 VICTORIA SQUARE CITY: MONTREAL STATE: A8 ZIP: H2Y 2J3 SC 13D/A 1 jf13da-bellus_power.htm jf13da-bellus_power.htm
 
 

WASHINGTON, D.C. 20549
 
SCHEDULE 13D/A
 
Under the Securities Exchange Act of 1934
(Amendment No. 20)
 
BELLUS HEALTH INC.
(Name of Company)
 
COMMON SHARES, NO PAR VALUE
(Title of class of securities)
 
07986A101
(CUSIP Number)
 
Dr. Francesco Bellini
Chairman and Chief Executive Officer
BELLUS Health Inc.
275 Armand Frappier Blvd.
Laval, Quebec H7V 4A7, Canada
(450) 680-4500
(Persons Authorized to Receive Notices and Communications)
December 9, 2008
 
(Date of Event which Requires Filing of this Statement)
 
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                  Page 2 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
P. P. Luxco Holdings II S.A.R.L.
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Luxembourg
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           0
 
8.
 
SHARED VOTING POWER                    11,087,382
 
9.
 
SOLE DISPOSITIVE POWER                  0
 
10.
 
SHARED DISPOSITIVE POWER           11,087,382 
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,087,382
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
22.2%
 
14.
 
 
TYPE OF REPORTING PERSON
CO

 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                  Page 3 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Picchio Pharma Inc.
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           0
 
8.
 
SHARED VOTING POWER                    11,450,429
 
9.
 
SOLE DISPOSITIVE POWER                  0
 
10.
 
SHARED DISPOSITIVE POWER           11,450,429
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,450,429
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
22.9%
 
14.
 
 
TYPE OF REPORTING PERSON
HC, CO
 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                  Page 4 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
FMRC Family Trust
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Alberta
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           0
 
8.
 
SHARED VOTING POWER                    11,706,4681
 
9.
 
SOLE DISPOSITIVE POWER                  0
 
10.
 
SHARED DISPOSITIVE POWER           11,706,4681
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,706,4681
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.4%
 
14.
 
 
TYPE OF REPORTING PERSON
OO
 
________________________
 
1
As described in Item 4 of amendment No. 17, FMRC is deemed to share beneficial ownership of the BELLUS Shares owned by each of Picchio and Luxco.
 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                  Page 5 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
John W. Churchill
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           0
 
8.
 
SHARED VOTING POWER                    11,706,468
 
9.
 
SOLE DISPOSITIVE POWER                  0
 
10.
 
SHARED DISPOSITIVE POWER           11,706,468
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,706,468
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.4%
 
14.
 
 
TYPE OF REPORTING PERSON
IN
 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                  Page 6 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Vernon H. Strang
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           0
 
8.
 
SHARED VOTING POWER                    11,706,468
 
9.
 
SOLE DISPOSITIVE POWER                  0
 
10.
 
SHARED DISPOSITIVE POWER           11,706,468
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,706,468
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.4%
 
14.
 
 
TYPE OF REPORTING PERSON
IN
 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                  Page 7 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Power Technology Investment Corporation
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           0
 
8.
 
SHARED VOTING POWER                    0
 
9.
 
SOLE DISPOSITIVE POWER                  0
 
10.
 
SHARED DISPOSITIVE POWER           0
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
 
14.
 
 
TYPE OF REPORTING PERSON
HC, CO
 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                  Page 8 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Victoria Square Ventures Inc.
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           1,172,704
 
8.
 
SHARED VOTING POWER                    11,450,4292
 
9.
 
SOLE DISPOSITIVE POWER                  1,172,704
 
10.
 
SHARED DISPOSITIVE POWER           11,450,4292
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,623,1332
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
25.2%
 
14.
 
 
TYPE OF REPORTING PERSON
HC, CO
 
________________________
 
2
Victoria Square Ventures Inc. (“VSV”) has acquired the BELLUS Shares and the Picchio shares previously owned by Power Technology Investment Corporation (“Power Tech”) and has succeeded to all of the contractual rights and obligations of Power Tech with respect thereto. As described in Item 6 as amended in amendment No. 14, VSV (in the place of Power Tech) has tracking stock rights with respect to 5,534,184 of the BELLUS Shares directly owned by Luxco.  Pursuant to such rights, VSV may request the disposition of up to 5,534,184 of the BELLUS Shares held by Luxco and included in the amounts given above.  To exercise such rights, VSV must request the other shareholders of Picchio to assist it in causing Luxco to dispose of up to all 5,534,184 BELLUS Shares with respect to which VSV has tracking stock rights.  Such other shareholders of Picchio have agreed that upon such request they will use all commercially reasonable efforts, subject to applicable law and agreements, to cause Luxco to dispose of the shares in accordance with VSV's request.  The net proceeds of such sale would be distributed to VSV as a dividend on the Class P Special Shares of Picchio held by VSV.  In addition, Rocabe Investments Inc. (in the place of FMRC and 18056 Yukon Inc.) has corresponding tracking stock rights with respect to the remaining 5,534,184 BELLUS Shares directly owned by Luxco and included in the amounts given above.
 
 
 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                  Page 9 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Dr. Francesco Bellini
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
PF
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           518,5413
 
8.
 
SHARED VOTING POWER                    1,484,1844
 
9.
 
SOLE DISPOSITIVE POWER                  518,5413
 
10.
 
SHARED DISPOSITIVE POWER           1,484,1844
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,002,7255
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4%
 
14.
 
 
TYPE OF REPORTING PERSON
IN
 
3
Includes 178,541 common shares directly owned by Dr. Bellini, 200,000 common shares issuable under currently exercisable options and 140,000 common shares which Dr. Bellini is entitled to receive pursuant to the Agreement with the Company of December 1, 2004 disclosed in Amendment No. 6 hereto, and for which regulatory and shareholder approval have been obtained.
 
4
Includes 1,484,184 common shares held of record by Dr. Bellini's wife and which he may be deemed to beneficially own.
 
5
Includes 178,541 common shares directly owned by Dr. Bellini, 200,000 common shares issuable under currently exercisable options, 140,000 common shares which Dr. Bellini is entitled to receive pursuant to the Agreement with the Company of December 1, 2004 disclosed in Amendment No. 6 hereto, and for which regulatory and shareholder approval have been obtained, and 1,484,184  common shares held of record by Dr. Bellini's wife and which he may be deemed to beneficially own.
 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                 Page 10 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Roberto Bellini
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Alberta
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           53,700
 
8.
 
SHARED VOTING POWER                    0
 
9.
 
SOLE DISPOSITIVE POWER                  53,700
 
10.
 
SHARED DISPOSITIVE POWER           5,534,1846
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,587,884
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.2%
 
14.
 
 
TYPE OF REPORTING PERSON
IN
 
________________________
 
1
Includes all of Rocabe Investments Inc.'s tracking stock rights received from 18056 Yukon Inc. (which received such rights from 1324286 Alberta Ltd. which in turn received such rights from FMRC) with respect to 5,534,184 of the BELLUS Shares directly owned by Luxco (originally disclosed in Item 6 as amended in amendment No. 14, and as amended in Item 4 of amendment No. 16 and Item 4 of amendment No. 17).
 
 
 

CUSIP No.   07986A101                                                                                                           Schedule 13D                                                                                                                 Page 11 of  30 pages
 
 
 
1.
 
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Carlo Bellini
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)     (a) ¨
                              (b) ¨
 
3.
 
 
SEC USE ONLY
 
4.
 
 
SOURCE OF FUNDS ( See Instructions)
N/A
 
5.
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)                ¨
 
6.
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
7.
 
SOLE VOTING POWER                           64,200
 
8.
 
SHARED VOTING POWER                    0
 
9.
 
SOLE DISPOSITIVE POWER                  64,200
 
10.
 
SHARED DISPOSITIVE POWER           5,534,1847
 
11.
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,598,384
 
   12.
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES    ¨
 
13.
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.2%
 
14.
 
 
TYPE OF REPORTING PERSON
IN
 
________________________
 
1
Includes all of Rocabe Investments Inc.'s tracking stock rights received from 18056 Yukon Inc. (which received such rights from 1324286 Alberta Ltd. which in turn received such rights from FMRC) with respect to 5,534,184 of the BELLUS Shares directly owned by Luxco (originally disclosed in Item 6 as amended in amendment No. 14, and as amended in Item 4 of amendment No. 16 and Item 4 of amendment No. 17).
 

 
 
This Amendment No. 20 amends the Schedule 13D filed on October 3, 2003, as amended, including as amended by the most recent amendment filed on November 5, 2008 (the "Statement"), and is filed by (i) P.P. Luxco Holdings II S.A.R.L., (ii) Picchio Pharma, Inc., (iii) FMRC Family Trust, (iv) John W. Churchill, (v) Vernon H. Strang, (vi) Power Technology Investment Corporation, (vii) Victoria Square Ventures Inc., (viii) Dr. Francesco Bellini, (ix) Roberto Bellini and (x) Carlo Bellini, relating to the common shares, no par value (the "BELLUS Shares"), of BELLUS Health Inc. (formerly known as Neurochem Inc.), a corporation organized under the Canada Business Corporations Act (the "Company").  Unless otherwise indicated, all capitalized terms used herein shall have the meanings given to them in the Statement, and unless amended hereby, all information previously filed remains in effect.  All dollar amounts are in Canadian dollars.
 
This Amendment No. 20 is filed as a result of the sale, transfer and assignment by Power Technology Investment Corporation (“Power Tech”) to Victoria Square Ventures Inc. (“VSV”) of all of Power Tech’s BELLUS Shares, all of Power Tech’s securities interests in Picchio, and all of its contractual rights and obligations with respect thereto.
 
ITEM 2.                      IDENTITY AND BACKGROUND
 
The first paragraph of Item 2 is amended and restated to read in its entirety as follows:
 
The Statement is being filed by P.P. Luxco Holdings II S.A.R.L. (“Luxco”), Picchio Pharma Inc. (“Picchio”), FMRC Family Trust (“FMRC”), John W. Churchill, Vernon H. Strang, Power Technology Investment Corporation (“Power Tech”), Victoria Square Ventures Inc. (“VSV”), Dr. Francesco Bellini, Roberto Bellini and Carlo Bellini (the “Filing Persons”).
 
The seventh paragraph of Item 2 is hereby amended and restated to read in its entirety as follows:
 
VSV is a corporation duly incorporated under the Canada Business Corporations Act, having its head office at 751 Victoria Square, Montreal, province of Quebec, H2Y 2J3.
 
The eleventh paragraph of Item 2 is hereby amended and restated to read in its entirety as follows:
 
VSV is wholly owned by Power Corporation of Canada (“Power Corp”) and as a result of direct and indirect securities holdings, may be deemed to be controlled by Mr. Paul G. Desmarais. Power Corp., a corporation organized under the laws of Canada, is a diversified management and holding company, and its principal business address is 751 Square Victoria, Montreal (Quebec), Canada H2Y 2J3. The name, citizenship, occupation and principal business address of each of the directors and executive officers of Power Corp. are listed on Exhibit A. Mr. Paul G. Desmarais, a citizen of Canada, has his principal business address at 751 Square Victoria, Montreal (Quebec), Canada H2Y 2J3. Exhibit B hereto identifies additional persons through whom Mr. Paul G. Desmarais may be deemed to control Power Corp., and, in turn, VSV. The filing of this Statement, including the Exhibits, shall not be construed as an admission that any of the control relationships enumerated herein actually exist.
 
The paragraph identifying Carlo Bellini is hereby amended to read in its entirely as follows:
 
Carlo Bellini is Executive Director of Domodimonti Snc. Società Agrcola. He is also a beneficiary of FMRC. His principal business address is Flat 302, Sussex Mansions, 65-85 Old Brompton Road, SW7 3LB London, United Kingdom. Carlo Bellini is a Canadian citizen.
 
ITEM 3.                      SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
 
Item 3 is hereby amended by adding the following at the end thereof:
 
On December 9 2008, VSV acquired from Power Tech (i) 1,172,704 BELLUS Shares, (ii) US$7,000,000 Convertible Senior Note (the “Notes”) issued by the Company, (iii) 40,884,302 class A common shares of Picchio, (iv) 36,066,667 class P special shares of Picchio, and (v) 11,300,000 preferred shares of Picchio (collectively, the “BELLUS Related Assets”). The purchase price for the 1,172,704 BELLUS Shares was $586,352. The purchase price for the US$7,000,000 Notes was $210,596, and the purchase price for the 36,066,667 class P special shares of Picchio was $1.00. VSV used general corporate funds of its shareholder and parent company, Power Corp., to purchase the BELLUS Shares and Notes.
 
On various dates from November 18, 2008 to December 9, 2008, Dr. Francesco Bellini’s wife, Marisa Bellini, used an aggregate of $137,808 in personal funds to acquire an aggregate of 254,912 BELLUS Shares in market transactions.
 
ITEM 4.                      PURPOSE OF TRANSACTION
 
Item 4 is hereby amended by adding the following at the end thereof:
 
The transfer of securities of the Company and Picchio by Power Tech to VSV is a result of an internal restructuring by Power Corp. of certain assets. This transfer did not change the direct or indirect beneficial ownership of any of the Filing Persons except to substitute VSV for the Power Tech beneficial ownership.
 
In connection with the transfer of the BELLUS Related Assets from Power Tech to VSV, (1) VSV intervened in the Amended and Restated Shareholders Agreement by and among Power Tech, FMRC, Dr. Bellini and Picchio dated November 9, 2006 (the “Shareholders Agreement”) and agreed to be bound by the terms and conditions of the Shareholders Agreement as if it were an original party thereto, and (2) VSV succeeded to all rights and obligations of Power Tech with respect to the BELLUS Related Assets under any and all other agreements. See the shareholders Consent dated December 9, 2008, and the Intervention between VSV and Power Tech dated December 9, 2008, which are attached as Exhibits KK and LL respectively.
 
The purpose of the purchases by Marisa Bellini described in Item 3 above was to increase Marisa Bellini’s direct percentage ownership of the Company.
 
ITEM 5.                      INTEREST IN SECURITIES OF THE COMPANY
 
All references to Power Tech in subsection (a) and (b) of Item 5 of the Statement are amended to read VSV. All references to BELLUS Shares owned by Marisa Bellini in subsection (a) and (b) of Item 5 are amended to refer to her ownership of 1,484,184  BELLUS Shares.
 
The tenth paragraph of subsection (a) of Item 5 is amended and restated to read in its entirety as follows:
 
Certain directors and executive officers of Power Corp. or VSV, or their spouses, own BELLUS Shares as follows (number of BELLUS Shares in parentheses): (A) Peter Kruyt (110,700), of which 42,700 are subject to options which are currently exercisable or exercisable within 60 days; (B) Andre Desmarais (221,800), of which 11,800 are subject to options which are currently exercisable or exercisable within 60 days, 60,000 of which are held of record by his wife and which he may be deemed to beneficially own, and 100,000 of which are held of record by a holding company he controls and which he may be deemed to beneficially own; and (C) Luc Jobin (2,000). Messrs. Kruyt and Jobin are also Directors of Picchio, and Mr. Andre Desmarais is a Director and the Deputy-Chairman of Picchio.  In addition, John A. Rae, a Director and Executive Vice President of Power Corp., is the Chair of the Board of Trustees of Queen's University at Kingston, Ontario, which owns 84,058 BELLUS Shares.  John A. Rae disclaims beneficial ownership of those shares.
 
Subsection (c) of Item 5 is amended to add the following at the end thereof:
 
On December 9 2008, VSV acquired from Power Tech (i) 1,172,704 BELLUS Shares for a purchase price of $586,352, and (ii) US$7,000,000 Notes issued by the Company for a purchase price of $210,596, and (iii) 36,066,667 class P special shares of Picchio for a purchase price of $1.00.
 
On October 27, 2008, Andre Desmarais’ wife bought in the open market 24,500 BELLUS Shares for a purchase price of $26,375, and on October 28, 2008 she bought an additional 15,500 BELLUS Shares for $11,625. On October 8, 2008 Paul Desmarais Jr.'s spouse sold in the open market 1,500 BELLUS Shares for $1,140.
 
Between November 18, 2008 and December 9, 2008, Marisa Bellini made the following purchases of BELLUS Shares:
 
Date
Shares Purchased
Price
11/18/08
25,000
$0.56
11/18/2008
25,000
$0.55
11/21/2008
10,000
$0.55
11/24/2008
10,000
$0.54
11/24/2008
10,000
$0.55
11/25/2008
10,000
$0.54
11/25/2008
10,000
$0.53
12/2/2008
36,500
$0.59
12/2/2008
200
$0.62
12/4/2008
28,054
$0.57
12/5/2008
10,000
$0.50
12/5/2008
37,699
$0.50
12/8/2008
10,200
$0.48
12/8/2008
10,000
$0.50
12/9/2008
22,259
$0.50
 

ITEM 6.      CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER

Item 3 and item 4 of this Amendment are incorporated by reference in this Item 6.

Item 6 is hereby amended by adding the following at the end thereof:
 
In December 2008, the holders of a majority of the Notes consented to a First Amendment to the Indenture governing the Notes, amending the provisions of the Indenture relating to the listing of the BELLUS Shares on an exchange. Under the Indenture as so amended, the holders of the Notes may not declare an event of default if the BELLUS Shares cease to be listed on a U.S. national securities exchange, so long as the BELLUS Shares continue to be listed on the Toronto Stock Exchange or another recognized securities exchange. Power Tech and FMRC were among the beneficial owners of the Notes consenting to the amendment. The Form of the First Amendment to the Indenture is attached as Exhibit MM hereto.
 

ITEM 7.      MATERIALS TO BE FILED AS EXHIBITS

The following Exhibits are filed herewith:
 
A.
Directors and Executive Officers of Power Corporation of Canada.
B.
Persons who may be deemed in control of Victoria Square Ventures Inc.
C.
Directors and Executive Officers of the Filing Persons.
KK.
Consent by 1324286 Alberta Ltd., Rocabe Investments Inc., and Power Technology Investment Corporation to transfer of the Picchio Pharma Inc. shares held by Power Technology Investment Corporation to Victoria Square Ventures Inc. dated December 9, 2008.
LL.
Intervention between Victoria Square Ventures Inc. and Power Technology Investment Corporation dated December 9, 2008.
MM.
Form of First Amendment to the Indenture between BELLUS Health Inc. and The Bank of New York Mellon, as trustee
 
 
 

 
 
SIGNATURE

 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
  P.P. LUXCO HOLDINGS II S.A.R.L.  
       
 
By:
/s/ Dr. Francesco Bellini  
    Name:  Dr. Francesco Bellini  
    Title:    Manager  
       
 
By:
/s/ Jean-Christophe Dauphin  
    Name:  Jean-Christophe Dauphin  
    Title:    Manager  
       
 
 
 
 

 


SIGNATURE
 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
  PICCHIO PHARMA INC.  
       
 
By:
/s/ Dr. Francesco Bellini  
    Name:  Dr. Francesco Bellini  
    Title:    Chairman and Director  
       
 
 
 
 
 


SIGNATURE
 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
  FMRC FAMILY TRUST  
       
 
By:
/s/ Vernon H. Strang  
    Name:  Vernon H. Strang  
    Title:    Trustee  
       
 
 
 
 
 

 
SIGNATURE
 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
 
/s/ John W. Churchill  
    JOHN W. CHURCHILL, Trustee  
       
       
 
 

 

 
 
SIGNATURE
 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
 
 
/s/ Vernon H. Strang  
    VERNON H. STRANG, Trustee  
       
       
 
 


 
 
SIGNATURE
 


 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
  POWER TECHNOLOGY INVESTMENT CORPORATION  
       
 
By:
/s/ Peter Kruyt  
    Name:  Peter Kruyt  
    Title:    President  
       
 
 
 
 

 


SIGNATURE
 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
  VICTORIA SQUARE VENTURES INC.  
       
 
By:
/s/ Stephane Lemay  
    Name:  Stephane Lemay  
    Title:    Vice-President  
       
 
 
 
 
 


SIGNATURE
 

 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
 
 
/s/ Dr. Francesco Bellini  
    DR. FRANCESCO BELLINI  
       
       
 
 


 

SIGNATURE
 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
 
 
/s/ Roberto Bellini  
    ROBERTO BELLINI  
       
       
 
 


 

SIGNATURE
 
After reasonable inquiry and to the best of our knowledge and belief, the Reporting Person certifies that the information set forth in this statement is true, complete and correct.
 
Dated: December 10, 2008
 
 
 
 
/s/ Carlo Bellini  
    CARLO BELLINI  
       
       
 
 

 
 



EXHIBIT INDEX
 
EXHIBIT NAME
 

 
 A.
Directors and Executive Officers of Power Corporation of Canada.
 B.
Persons who may be deemed in control of Victoria Square Ventures Inc.
 C.
Directors and Executive Officers of the Filing Persons.
 D.
Subscription Agreement by and among Neurochem Inc., P.P. Luxco Holdings II S.A.R.L. and Picchio Pharma Inc., dated July 25, 2002. 1
 E.
Amended and Restated Shareholders Agreement, dated November 9, 2006 by and among Power Investment Technology Corporation, FMRC Family Trust, Picchio Pharma Inc. and Dr. Francesco Bellini. 11
 F.
Warrant dated July 25, 2002. 1
 G.
Warrant dated February 18, 2003.1
 H.
Joint Filing Agreement. 11
 I.
Memorandum of Agreement between Torquay Consultadoria y Servicios LDA and Power Tech, dated May 5, 2004, with an effective date of May 6, 2004.2
 J.
Waiver to the Shareholders Agreement, as amended, by and among Power Tech, Vernon H. Strang, FMRC, Picchio, and Dr. Bellini, effective as of April 30, 2004. 2
 K.
Waiver to the Shareholders Agreement, as amended, by and among Power Tech, Vernon H. Strang, FMRC, Picchio, and Dr. Bellini, effective as of May 27, 2004 up until August 31, 2004. 11
 L.
Memorandum of Agreement, dated as of May 28, 2004, by and between DKR Saturn Event Driven Holding Fund Ltd. and Power Tech.3
 M.
Memorandum of Agreement, dated as of May 28, 2004, by and between DKR Saturn Multi-Strategy Holding Fund Ltd. and Power Tech.3
 N.
Memorandum of Agreement, dated as of July 22, 2004, by and between Viking Global Equities LP and Power Tech.3
 O.
Memorandum of Agreement, dated as of July 22, 2004, by and between VGE III Portfolio Ltd. and Power Tech.3
 P.
Credit Agreement, dated as of July 30, 2004, by and between Picchio and National Bank of Canada.4
 Q.
Pledge Agreement, dated July 30, 2004 by and between Luxco and National Bank of Canada.4
 R.
Guarantee Agreement, dated July 30, 2004 by and between Luxco and National Bank of Canada.4
 S.
Commitment Letter, dated February 14, 2005.5
 T.
Agreement made as of December 1, 2004 by and between  the Company and Dr. Bellini.5
 U.
Waiver to the Shareholders Agreement, as amended, by and among Power Tech, Vernon H. Strang, FMRC, Picchio, and Dr. Bellini, effective as of March 3, 2005.6
 V.
Acknowledgement of Debt, made on March 9, 2005, by and between Vern Strang As Trustee of The FMRC Family Trust and 18056 Yukon Inc.6
 W.
Underwriting Agreement by and among Neurochem Inc., UBS Securities LLC, CIBC World Markets Corp., Piper Jaffray & Co., Desjardins Securities Inc., Wells Fargo Securities, LLC, BMO Nesbitt Burns Inc., and Fortis Securities LLC (Incorporated by reference to Exhibit 3 to the Company's registration statement on Form F-10 filed with the Securities and Exchange Commission (file no. 333-122965) on March 4, 2005).
 X.
Notice of Pledge, dated April 21, 2005, by Luxco to National Bank of Canada. 6
 Y.
Credit Agreement, dated January 26, 2006 by and between Picchio and National Bank of Canada.7
 Z.
Guarantee Agreement, dated January 26, 2006 by and between Luxco and National Bank of Canada.7
 AA.
Pledge Agreement, dated January 26, 2006 by and between Luxco and National Bank of Canada.7
 BB.
Indenture dated as of November 9, 2006 by and between the Company and The Bank of New York, as trustee.7
 CC.
Registration Rights Agreement dated as of November 9, 2006 by and between the Company and UBS Securities LLC.8
 DD.
Voting Agreement dated as of May 1, 2007 by and among the Company and the Shareholders.9
 EE.
Lock-Up Agreement dated as of May 1, 2007 by and among the Company and Dr. Bellini.12
 FF.
Consent and Intervention dated July 12, 2007 by and among Vern Strang es qualité Trustee of The FMRC Family Trust, Dr. Francesco Bellini, 18056 Yukon Inc., 1324286 Alberta Ltd., Power Technology Investment Corporation and Picchio Pharma Inc.10
 GG.
Consent, Intervention and Amendment, dated October 17, 2007 by and among 18056 Yukon Inc., Rocabe Investments Inc., Roberto Bellini, Carlo Bellini, Power Technology Investment Corporation, Picchio Pharma Inc., Vern Strang as trustee of FMRC Family Trust, Dr. Francesco Bellini and 1324286 Alberta Ltd.11
 HH.
Promissory Note dated October 17, 2007. 11
 II.
Letter dated October 23, 2008 from Dr. Francesco Bellini to BELLUS Health Inc., Picchio Pharma Inc. and Power Technology Investment Corporation.13
 JJ.
Press Release dated October 21, 2008 issued by BELLUS Health Inc.13
 KK.
Consent by 1324286 Alberta Ltd., Rocabe Investments Inc., and Power Technology Investment Corporation to transfer of the Picchio Pharma Inc. shares held by Power Technology Investment Corporation to Victoria Square Ventures Inc. dated December 9, 2008.
 LL.
Intervention between Victoria Square Ventures Inc. and Power Technology Investment Corporation dated December 9, 2008.
 MM.
Form of First Amendment to the Indenture between BELLUS Health Inc. and The Bank of New York Mellon, as trustee.

_____________________

1
Previously filed with Schedule 13D on October 3, 2003.
2
Previously filed with Amendment No. 2 to Schedule 13D on May 11, 2004.
3
Previously filed with Amendment No. 3 to Schedule 13D on July 26, 2004.
4
Previously filed with Amendment No. 4 to Schedule 13D on August 2, 2004.
5
Previously filed with Amendment No. 7 to Schedule 13D on March 9, 2005.
6
Previously filed with Amendment No. 8 to Schedule 13D on April 25, 2005.
7
Previously filed with Amendment No. 12 to Schedule 13D on August 22, 2006.
8
Previously filed with Amendment No. 14 to Schedule 13D on November 13, 2006.
9
Previously filed with Amendment No. 15 to Schedule 13D on May 3, 2007.
10
Previously filed with Amendment No. 16 to Schedule 13D on July 16, 2007.
11
Previously filed with Amendment No. 17 to Schedule 13D on October 22, 2007.
12
Previously filed with Amendment No. 18 to Schedule 13D on March 20, 2008.
13
Previously filed with Amendment No. 19 to Schedule 13D on November 5, 2008.

EX-99.A 2 ex_a.htm ex_a.htm
 
 
Exhibit A
 
DIRECTORS AND EXECUTIVE OFFICERS OF POWER CORPORATION OF CANADA
 
The (i) name, (ii) title, (iii) country of citizenship, (iv) principal occupation and (v) principal business address of each of the directors and executive officers of the Filing Persons are listed below.
 
(i)
Laurent Dassault
(ii)
Director
(iii)
France
(iv)
Vice-President
(v)
Groupe Industriel Marcel Dassault SA
9, Rond-Point des Champs-Elysees
75008 Paris, France
   
(i)
Andre Desmarais
(ii)
Director and Executive Officer
(iii)
Canada
(iv)
Deputy Chairman, President and Co-Chief Executive Officer, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Paul G. Desmarais, P.C., C.C
(ii)
Director
(iii)
Canada
(iv)
Chairman of the Executive Committee, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Paul Desmarais, Jr.
(ii)
Director and Executive Officer
(iii)
Canada
(iv)
Chairman and Co-Chief Executive Officer, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Anthony R. Graham
(ii)
Director
(iii)
Canada
(iv)
President, Wittington Investments, Limited
(v)
Wittington Investments, Limited
22 St. Clair Avenue East
Suite 2001
Toronto, ON  M4T 2S7
   
(i)
Robert Gratton
(ii)
Director and Executive Officer
(iii)
Canada
(iv)
Deputy Chairman, Power Corporation of Canada
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Edward Johnnson
(ii)
Executive Officer
(iii)
Canada
(iv)
Senior Vice-President, General Counsel and Secretary, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Peter Kruyt
(ii)
Executive Officer
(iii)
Canada
(iv)
Vice-President, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Denis Le Vasseur
(ii)
Executive Officer
(iii)
Canada
(iv)
Vice-President and Controller, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
The Right Honourable Donald F. Mazankowski
(ii)
Director
(iii)
Canada
(iv)
Company Director, Business Consultant
(v)
80 Nottingham Inlet
Sherwood Park, AB T8A 6N2
   
(i)
Jerry E.A. Nickerson
(ii)
Director
(iii)
Canada
(iv)
Chairman of the Board, H.B. Nickerson & Sons Limited
(v)
H.B. Nickerson & Sons Limited
255 Commercial
North Sydney, NS B2A 1B9
   
(i)
Dr. James R. Nininger
(ii)
Director
(iii)
Canada
(iv)
Company Director, Power Corp.
(v)
17 Dow's Lake Road
Ottawa, ON K1S 4L1
   
(i)
Robert Parizeau
(ii)
Director
(iii)
Canada
(iv)
Chairman, Aon Parizeau Inc.
(v)
Aon Parizeau Inc.
700 de la Gauchetiere St. West
Suite 1600
Montreal, QC H3B 0A4
   
(i)
Michel Plessis-Belair
(ii)
Director and Executive Officer
(iii)
Canada
(iv)
Vice-Chairman, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Philip K. Ryan
(ii)
Executive officer
(iii)
Canada
(iv)
Executive Vice-President and Chief Financial Officer
 
Power Corp. and Power Financial Corporation
(v)
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
John A. Rae
(ii)
Director and Executive Officer
(iii)
Canada
(iv)
Exec. VP, Office of the Chairman of the Exec. Committee, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Amaury de Seze
(ii)
Director and Executive Officer
(iii)
France
(iv)
Vice-Chairman, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Dr. Emoke J.E. Szathmary
(ii)
Director
(iii)
Canada
(iv)
President Emeritus, University of Manitoba
(v)
University of Manitoba
St. Paul’s College, Room 112
70 Dysart Road
Winnipeg, MB R3T 2M6
   
(i)
Gerard Veilleux
(ii)
Executive Officer
(iii)
Canada
(iv)
Vice-President, Power Corp. & President of Power Communications Inc.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Arnaud Vial
(ii)
Executive Officer
(iii)
Canada and France
(iv)
Senior Vice-President, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Luc Jobin
(ii)
Executive Officer
(iii)
Canada
(iv)
Executive Vice President, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Pierre Beaudoin
(ii)
Director
(iii)
Canada
(iv)
President and Chief Executive Officer, Bombardier Inc.
(v)
Bombardier Inc.
800 René-Léveque West, 30th Floor
Montreal QC H3B 1Y8
   
(i)
R. Jeffrey Orr
(ii)
Director
(iii)
Canada
(iv)
President and CEO, Power Financial Corporation
(v)
Power Financial Corporation
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Daniel Friedberg
(ii)
Executive Officer
(iii)
Canada
(iv)
Vice President, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Stéphane Lemay
(ii)
Executive Officer
(iii)
Canada
(iv)
Vice-President and Assistant General Counsel, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Luc Reny
(ii)
Executive Officer
(iii)
Canada
(iv)
Vice-President, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Raymond McFeetors
(ii)
Director
(iii)
Canada
(iv)
Chairman, Great-West Lifeco Inc.
(v)
100 Osborne Street
Winnipeg MB R3C 3A5
   
(i)
Richard Pan
(ii)
Executive Officer
(iii)
Canada
(iv)
Vice-President, Head of Corporate Finance, Power Corp.
(v)
Power Corporation of Canada
751 Victoria Square
Montreal, QC H2Y 2J3
 
 
 
EX-99.B 3 ex_b.htm ex_b.htm
 
 
 
EXHIBIT B




PERSONS WHO MAY BE DEEMED IN CONTROL OF
VICTORIA SQUARE VENTURES INC.


Set forth below is the (i) name, (ii) principal business address and (iii) citizenship or place of organization of each person who may be deemed, for purposes of this Statement, to control the Filing Persons.
 
(i)  
Power Corporation of Canada
(ii)  
751 Square Victoria, Montreal (Quebec), Canada H2Y 2J3
(iii)  
Canada

(i)  
Gelco Enterprises Ltd.
(ii)  
40 Wellington Row, P.O. Box 6850, Station A, St. Johns, News Brunswick, Canada E2L 453
(iii)  
Canada

(i)  
Nordex Inc.
(ii)  
40 Wellington Row, P.O. Box 6850, Station A, St. Johns, News Brunswick, Canada E2L 453
(iii)  
Canada

(i)  
Paul G. Desmarais
(ii)  
751 Square Victoria, Montreal (Quebec), Canada H2Y 2J3
(iii)  
Canada
EX-99.C 4 ex_c.htm ex_c.htm
 
 
EXHIBIT C
 
DIRECTORS AND EXECUTIVE OFFICERS OF THE FILING PERSONS
 
The (i) name, (ii) title, (iii) country of citizenship, (iv) principal occupation and (v) principal business address of each of the directors and executive officers of the Filing Persons are listed below.
 
I.P.P. LUXCO HOLDINGS II S.A.R.L.
 
(i)
Dr. Francesco Bellini
   
(ii)
Manager
   
(iii)
Canada
   
(iv)
Chief Executive Officer, BELLUS Health Inc.
   
(v)
Picchio International Inc.,
759 Square Victoria, Suite 224, Montreal (Quebec), H2Y 2J7, Canada
   
(i)
Carl Speecke
   
(ii)
Manager
   
(iii)
Luxembourg
   
(iv)
Fortis Intertrust Luxembourg
   
(v)
65, Boulevard Grande Duchesse Charlotte,
1331 Luxembourg, Grand-Duchy of Luxembourg
   
(i)
Jean-Christophe Dauphin
   
(ii)
Manager
   
(iii)
Luxembourg
   
(iv)
Fortis Intertrust Luxembourg
   
(v)
65, Boulevard Grande Duchesse Charlotte,
1331 Luxembourg, Grand-Duchy of Luxembourg
   

II.           PICCHIO PHARMA INC.
 
(i)
Andre Desmarais
   
(ii)
Deputy-Chairman and Director
   
(iii)
Canada
   
(iv)
President and Co-Chief Executive Officer, Power Corp.
   
(v)
751 Square Victoria,
Montreal, Quebec, H2Y 2J3, Canada
   
(i)
Dr. Francesco Bellini
   
(ii)
Chairman, President and Director
   
(iii)
Canada
   
(iv)
Chief Executive Officer, BELLUS Health Inc.
   
(v)
Picchio International Inc.,
759 Square Victoria, Suite 224, Montreal (Quebec), H2Y 2J7, Canada
   
(i)
Charles Cavell
   
(ii)
Director
   
(iii)
Canada
   
(iv)
Retired
   
(v)
c/o Picchio International Inc.,
759 Square Victoria, Suite 224, Montreal (Quebec), H2Y 2J7, Canada
   
(i)
Peter Kruyt
   
(ii)
Director
   
(iii)
Canada
   
(iv)
Vice President, Power Corp.
   
(v)
751 Square Victoria,
Montreal, Quebec, H2Y 2J3, Canada
   
(i)
Dr. Gervais Dionne
   
(ii)
Director
   
(iii)
Canada
   
(iv)
Chief Executive Officer
   
(v)
Virochem Pharma Inc.
275 Armand-Frappier Blvd.
Laval, QC H7V 4A7
   
(i)
Marisa Bellini
   
(ii)
Director
   
(iii)
Canada
   
(iv)
Director, Picchio International Inc.
   
(v)
Picchio International Inc.,
759 Square Victoria, Suite 224, Montreal, Quebec H2Y 2J7
   
(i)
Pierre Larochelle
   
(ii)
Director
   
(iii)
Canada
   
(iv)
President and Chief Executive Officer, Adaltis Inc.
   
(v)
Adaltis Inc.,
10, 900 Hamon,
Montreal, Quebec H3M 3A2, Canada
   
(i)
Luc Jobin
   
(ii)
Director
   
(iii)
Canada
   
(iv)
Exec. Vice President of Power Corp.
   
(v)
Power Corporation of Canada,
751 Victoria Square,
Montreal, Quebec, H2Y 2173, Canada
   
(i)
Martin Cauchon
   
(ii)
Director
   
(iii)
Canada
   
(iv)
Attorney, Gowling Lafleur Henderson LLP
   
(v)
Gowling Lafleur Henderson LLP
1 Place Ville Marie, 37th Floor, Montreal, Quebec, H3B 3P4, Canada
   
(i)
Roberto Bellini
   
(ii)
Executive Vice President
   
(iii)
Canada
   
(iv)
Picchio Pharma Inc.
   
(v)
759 Square Victoria, Suite 224, Montreal, Quebec H2Y 2J7
   

III.           FMRC FAMILY TRUST
 
(i)
John W. Churchill
   
(ii)
Trustee, FMRC Trust
   
(iii)
Canada
   
(iv)
Chartered Accountant (Retired)
   
(v)
10627 Bradbury Drive SW
Calgary, Alberta, T2W 1A9
   
(i)
Vernon H. Strang
   
(ii)
Trustee, FMRC Trust
   
(iii)
Canada
   
(iv)
Chartered Accountant (Retired)
   
(v)
39 Scimitar View NW
Calgary, Alberta, T3L 2B4
   

IV.           VICTORIA SQUARE VENTURES INC.
 
(i)
Edward Johnson
   
(ii)
Director and Executive Officer
   
(iii)
Canada
   
(iv)
Vice President and Secretary, VSV
   
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Arnaud Vial
   
(ii)
Director and Executive Officer
   
(iii)
Canada
   
(iv)
Vice President, VSV
   
(v)
Power Corporation of Canada
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Philip K. Ryan
   
(ii)
Director and Executive Officer
   
(iii)
Canada
   
(iv)
President and Chairman of the Board, VSV
   
(v)
40 Belvedere Road
Westmount, Quebec
Canada, H3Y 1P4
   
(i)
Stephane Lemay
   
(ii)
Executive Officer
   
(iii)
Canada
   
(iv)
Vice-President, VSV
   
(v)
751 Victoria Square
Montreal QC H2Y 2J3
   
(i)
Isabelle Morin
   
(ii)
Executive Officer
   
(iii)
Canada
   
(iv)
Treasurer, VSV
   
(v)
2656 des Andes
Ville St-Laurent, QC H4R 3G3

EX-99.KK 5 ex_kk.htm ex_kk.htm
 
 
PICCHIO PHARMA INC.
(the "Corporation")
 
CONSENT
 
Pursuant to and in conformity with the Amended and Restated Shareholders Agreement of the Corporation entered among all the shareholders of the Corporation as of November 9, 2006, the undersigned, being the holders of all the issued and outstanding shares in the capital of the Corporation, hereby consent to the following transfers of shares in the capital of the Corporation:
 
Transferor
Transferee
Number and
class of shares
Power Technology Investment Corporation
Victoria Square Ventures Inc.
40,884,302 class A common shares
36,066,667 class P special shares
11,300,000 Preferred Shares

 
Dated this ___ day of ______________, 2008.
 
 
1324286 ALBERTA LTD.
 
POWER TECHNOLOGY INVESTMENT CORPORATION
     
Per:
    Per:   
  Vern Strang    
Stéphane Lemay
       
       
     
ROCABE INVESTMENTS INC.
   
     
Per:
     
  Roberto Bellini    
EX-99.LL 6 ex_ll.htm ex_ll.htm
 
 
 
INTERVENTION
 

 
DATE:                                                                 , 2008
 

 
The undersigned, Victoria Square Ventures Inc., as the acquiror of 40,884,302 class A common shares, 36,066,667 class P special shares and 11,300,000 Preferred Shares of Picchio Pharma Inc. (the “Shares Transferred”), from Power Technology Investment Corporation, hereby (i) intervenes in the Amended and Restated Shareholders Agreement by and among Power Technology Investment Corporation, FMRC Family Trust, Dr. Francesco Bellini and Picchio Pharma Inc. dated as of November 9, 2006 (the “Agreement”) and (ii) agrees that it is bound by the terms and conditions of the Agreement as if it were an additional original party thereto.
 

 
VICTORIA SQUARE VENTURES INC.
 

 
Per:  __________________________________________         
 

 
POWER TECHNOLOGY INVESTMENT CORPORATION
 

Per:  __________________________________________         
 
EX-99.MM 7 ex_mm.htm ex_mm.htm
Exhibit MM
 
FORM OF
 
FIRST AMENDMENT TO INDENTURE
 
First Amendment, dated as of ____________ ___, 2008 (this “First Amendment”), to the Indenture, dated as of November 9, 2006 (the “Indenture”) between BELLUS Health Inc., a corporation (formerly known as Neurochem Inc.) organized under the Canada Business Corporations Act (the “Company”) and The Bank of New York Mellon (formerly known as The Bank of New York), as trustee (the “Trustee”).
 
WITNESSETH:
 
WHEREAS, Section 9.02 of the Indenture provides that the Company, with the consent of the Trustee, may amend the Indenture with the written consent of the Holders of at least a majority in aggregate principal amount of the Securities;
 
WHEREAS, Holders of at least a majority in aggregate principal amount of the Securities have consented in writing to this First Amendment;
 
NOW, THEREFORE, it is hereby agreed as follows:
 
1.    Termination of Trading.  The definition of the term “Termination of Trading” in Section 1.01 of the Indenture is hereby amended to read as follows in the entirety, effective as of the date of this First Amendment:
 
A “Termination of Trading” shall be deemed to occur if the Common Shares of the Company (or other common stock into which the Securities are then convertible (disregarding any cash payments for the principal return due upon conversion, cash payments permitted to be paid hereunder in lieu of other property otherwise due upon conversion, and cash due upon conversion in lieu of fractional shares)) is not listed for trading on a recognized securities exchange.  The Toronto Stock Exchange or any successor thereto (as well as any U.S.  national securities exchange) shall be deemed a recognized securities exchange.
 
2.    Other Capitalized Terms.  Capitalized terms used but not defined herein are used as defined in the Indenture.
 
3.    Indenture Otherwise Unchanged.  Other than as amended hereby, the Indenture shall remain unchanged and in full force and effect.
 
4.    Trustee Not Responsible.  The Trustee makes no representation as to the validity or sufficiency of this First Amendment.  The recitals and statements herein are deemed to be those of the Company and not the Trustee.
 
IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to be duly executed as of the date first above written.
 
 
  BELLUS HEALTH INC.  
     
       
 
By:
   
    Name:   Mariano Rodriguez  
       
    Title:     Vice President, Finance and CFO  
 
     
       
 
By:
   
    Name:   David Skinner  
       
    Title:     Vice President, General Counsel and Corporate Secretary  
       
 
 
THE BANK OF NEW YORK MELLON,
as Trustee
 
     
       
 
By:
   
    Name:    
       
    Title:      
       
 
-----END PRIVACY-ENHANCED MESSAGE-----